Celldex Therapeutics, Inc.
CLDX· Nasdaq
Released May 3, 2013, before the open
10-Q filed May 3, 2013, 33 days after period end · 0001104659-13-036833
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q1 2013 | Q1 2012 | Q1 2011 |
|---|---|---|---|
| Revenue | $2.41M | $2.43M | $2.52M |
| EPS Diluted | -$0.23 | -$0.27 | -$0.31 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Celldex Therapeutics, Inc. · CIK 744218 · Engraved from SEC EDGAR
ended Mar 31, 2013 · filed May 3, 2013 · 33 d after period end
+0.4% from the close of May 2, 2013 to the close of May 3, 2013, the first after the release.